BioStock: CLS predicts continued growth in 2025–2026

CLS presents its expectations for the next two years based on the strategic changes implemented in 2024. The company has shifted its focus to commercial partnerships and the neurosurgery segment while implementing extensive cost-saving measures. These initiatives are expected to strengthen the company’s financial performance and create a stable foundation for continued growth.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/01/cls-predicts-continued-growth-in-2025-2026/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se